Friday, May 8, 2020

⁣“Way more important than the money, we're bringing operational and automation expertise to the problem to dramatically increase their capacity and see if we can make a big dent in this backlog from U.S. hospitals of specimen kits”

View this post on Instagram

Apple will award $10 million to aid Copan Diagnostics, a top manufacturer of sample collection kits used in COVID-19 testing, in its efforts to ramp up production as U.S. hospitals contend with shortages of necessary supplies, the company announced Thursday. ⁣ ⁣Derived from Apple’s $5 billion Advanced Manufacturing Fund, the grant will allow Copan to produce more than 1 million kits per week by early July, up from several thousand per week at its current capacity. In addition, Apple will assist the medical supply firm with the sourcing of necessary materials and support Copan’s move into a larger facility based in Southern California. ⁣ ⁣“Way more important than the money, we're bringing operational and automation expertise to the problem to dramatically increase their capacity and see if we can make a big dent in this backlog from U.S. hospitals of specimen kits,” Apple Chief Operating Officer Jeff Williams said in an exclusive interview with Fox Business Network correspondent @susyqli. ⁣ ⁣Copan is the inventor and one of the world’s only manufacturers of flocked swabs, a design recommended by the U.S. Centers for Disease Control and Prevention for use in the collection of COVID-19 samples. The Italy-based company has faced unprecedented demand for collection and transport kits in recent months as the pandemic has intensified, straining its limited production capabilities. ⁣ ⁣The Trump administration and public health experts have identified enhanced coronavirus testing as a key component of efforts to reopen the U.S. economy after a weeks-long shutdown.

A post shared by Fox Business (@foxbusiness) on